Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Siddha MAM Granules: 2gms with milk morning and night after food for 14 dayswith Standard Allopathy Care (Vit C & Zinc)
Control Intervention1: Standard Allopathy Care (Vit C & Zinc): mi
Sponsors
Central Council for Research in Siddha
Government Institute of Medical Sciences GIMS
Eligibility
Inclusion criteria
Inclusion criteria: 1. Laboratory Confirmed COVID â?? 19 with Asymptomatic Patient (as per ICMR Guidelines) 30 Patients in each group 2. Aged 18-65 years 3. Consenting to participate in the study and sign the informed consent
Exclusion criteria
Exclusion criteria: 1. Patients with severe primary respiratory disease or other pathogenic microbial pneumonia 2. Patient with Uncontrolled DM (>= 350 mgs Fasting Sugar) Severe HT (180/120 mmHg as per JNC 8 Guidelines), Chronic BA (>= 5 years Based on Clinical History), Renal Dysfunction (Known CKD >= 5 years eGFR Stage >= 3 as per NKA guidelines) 3. Pregnant and Lactating mothers 4. People who have history of allergic to Siddha medicine or intolerant to taking medication 5. Patients participating in other COVID-19 clinical trials 6. Patients already went under COVID 19 vaccination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in incidence of clinical symptoms like fever, cough and breathlessness Negative conversion of SARS CoV - 2 by 14 days Reduction in Viral load of SARS CoV â?? 2 at the end of treatment Effect of drugs inflammatory markers (IL6) and other Immunity Markers at the end of treatment. Timepoint: 14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in incidence of complications (ARDS, other systematic complications) Laboratory markers (Hematological & Bio â?? Chemical Markers) Adverse events/effects Siddha-based measurements Siddha Udaliyal assessment by using YI Tool Timepoint: 14 Days | — |
Countries
India
Contacts
Public ContactDr Anurag Srivastava
Government Institute of Medical Sciences GIMS
Outcome results
None listed